Pressreleases

Strategikon Pharma Announces New Software Release of Clinical Maestro

Latest Version Establishes Clinical Maestro as a Digital Business Transformation Leader for Clinical Trials.

Gerresheimer with Positive Start to the Financial Year 2021

Organic revenue growth of 3.1 % in core business Strong development in High Value Solutions: Focus on Biological Solutions pays

Virtual Pharma Training Including New Digital eLearning

With over 30 years of training experience and subject matter experts who have stood in your shoes, benefit from NSF’s

Gerresheimer Sets Itself Ambitious Sustainability Targets as Part of its Corporate Strategy

Ambitious targets will direct Gerresheimer's sustainability strategy in the coming years. Among other things, the company wants to cut its

SGS Facilitates Selecta Biosciences and Askbio’s FIH Study to Evaluate Immtor™ in Gene Therapy

SGS is pleased to announce the support of Selecta Biosciences and Asklepios BioPharmaceutical (AskBio) Phase 1 dose-escalation trial of SEL-399, an adeno-associated viral serotype 8 (AAV8) vector capsid containing no transgene with ImmTOR™.

SGS Nominated for Best Contract Research Organization at the Vie Awards

SGS is excited to announce that we have been nominated for ‘Best Contract Research Organization’ at the Vaccine industry Excellence

Denny Bros Group Announce Plans to Become Employee-Owned

Denny Bros Group has announced exciting plans to become employee-owned. The group has restructured its ownership so that a majority

New Corporate Design Visualises Gerresheimer’s Strategic Orientation

The new corporate design visualises Gerresheimer’s strategic focus on profitable and sustainable growth, innovation, excellence and customer focus.

Gerresheimer AG extends CEO Dietmar Siemssen’s Contract by Five Years

At its meeting yesterday, the Supervisory Board of Gerresheimer AG extended the contract with CEO Dietmar Siemssen to the end of October 2026.